The NH125 compound is a widely-reported EEF2K inhibitor, which decreases cancer cell viability [19] by increasing EEF2 phosphorylation [20,21] to reduce mRNA translation into protein, leading to inhibition of tumour growth [21]. The gene discussed is EEF2K; the disease is neoplasm.